This modern, innovative product for treating hernias represents a completely new and safe solution and is a real alternative to surgery.

Intervertebral Hernia

Intervertebral hernias are the most common causes of back pain, as well as discomfort in the pelvic area and legs. They occur across all age groups.

The condition arises due to the protrusion of the intervertebral disc, which puts pressure on nearby nerve endings and spinal nerve roots.

If conservative treatment methods are ineffective, neurosurgical intervention is necessary. Surgical procedures on the spinal canal carry various risks of complications. After surgery, scars and adhesions inevitably form, which later cause symptoms similar to those of a disc hernia. This is known as the so-called failed back syndrome.

You can avoid these problems with intradiscal microtherapy using the drug DiscoGel!

What is DiscoGel?

DiscoGel® is an implantable medical product that contains:

  • Gelified ethanol (using cellulose)
  • Tungsten nanoparticles (contrast component for radiological visualization)

Mechanism of Action

  • DiscoGel® works via a physico-chemical mechanism: necrosis of the nucleus pulposus and its dehydration.
  • Ethanol absorbs water from the nucleus pulposus, causing immediate decompression and pain relief.
  • The protrusion is drawn back, relieving internal pressure on spinal nerve roots.

Procedure

  • Single administration of the gel.
  • Injection under local anesthesia into the intervertebral disc using a fine needle under radiological guidance.
  • Controlled via computed tomography for millimeter precision.
  • No scars or adhesions form on the skin or spinal canal.
  • Duration: 20–40 minutes.
  • Patients can leave the clinic 3 hours after the procedure.
  • Pain relief occurs within a few hours.

All procedures are performed in sterile conditions by a specially trained team: radiologists, orthopedic trauma specialists, surgeons, and anesthesiologists.

Form and Dosage

Kit includes:

  • 1 vial with 2 ml of sterile DiscoGel®
  • 2 sterile syringes (1.0 ml)
  • 1 sterile 19G needle for extraction
  • 2 sterile 18G needles for injection

Dosage:

  • 0.3 to 1.0 ml per disc (depending on disc and hernia size)

Contraindications

  • Coagulopathy
  • Infectious diseases
  • Spinal canal stenosis
  • Spondylolisthesis
  • Fractures and instability
  • Cauda equina syndrome

Use: Can treat any intervertebral disc hernia at cervical, thoracic, or lumbar levels.

Advantages of DiscoGel Compared to Other Methods

  • Completely innovative and safe
  • Treats any type of intervertebral disc hernia
  • Genuine alternative to surgery
  • No prolonged postoperative therapy or hospitalization
  • No allergic or inflammatory reactions
  • Immediate visible results, no scars or pain
  • High success rate: 90–95%
  • No recorded recurrences or complications (over 7 years follow-up)
  • Rapid results: return to normal activities in 1–3 weeks vs 3 months after traditional surgery

Results

Developed by French scientists in 2001

Offered in Moldova since 2013

Over 7 years: no recurrence of intervertebral disc hernia in patients

Only 0.7% of patients required additional treatment

Good to excellent outcomes:

>95% in uncomplicated, recent hernias

90% in chronic/complex hernias

Pain relief noticeable within hours; complete relief in 3 months, significant improvement within 3 weeks

Hospitalization Procedure

  • Stay in Chișinău (Moldova) for 4–5 days for intradiscal microtherapy

Additional Advanced Treatments

Cold Plasma Nucleoplasty